Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Shorenstein APARC
Encina Hall E332
616 Serra Street
Stanford, CA 94305-6055

(650) 724-5710 (510) 705-2049 (650) 723-6530
0
Developing Asia Health Policy Fellow
IMG_4537.jpg MD

Gendengarjaa Baigalimaa joins the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) during the 2013-2014 acedemic year as the Asia Health Policy Program Fellow. She joins APARC from the Mongolian National Cancer Center, where she serves as a Gynecological Oncologist.

During her appointment as Health Policy Fellow, she will conduct a comparative study of how knowledge of cervical cancer risk factors has influenced behavior changes in Mongolia before and after the introduction of the National Cervical Cancer Program.

Baigalimaa is the Executive Director of Mongolian Society of Gynecological Oncologists and is also a member of the International Gynecological Cancer Society (IGCS) in Mongolia, Russia, and France.

Baigalimaa holds a MD from Minsk Belarussia Medical University. She also received a Masters in Health Science from Mongolian Medical University. She is fluent in both Russian and English.

Authors
News Type
News
Date
Paragraphs

Millions of Americans who need to buy health insurance are eligible for federal subsidies. But the government may have underfunded the expense by billions of dollars, according to Stanford researchers.

In a recent article published in Health Affairs, the researchers expose the remarkable control employers will soon have on federal revenue. Employers will soon decide whether to continue providing health insurance to their employees, cut their coverage or increase premiums that workers pay. 

These choices will in part determine whether it will be financially beneficial for workers to buy insurance through the government’s new health insurance exchanges, rather than be insured through their employers.  And such decisions could change government expenditures by billions of dollars– a potential spending increase that the federal government has likely not accounted for.

"There’s going to be a lot more federal money required for insurance subsidies than people are ready for," said Jay Bhattacharya, an associate professor of medicine at Stanford and a core faculty member of Stanford Health Policy, a center at the university’s Freeman Spogli Institute for International Studies. Bhattacharya co-authored the study with medical students Daniel Austin, Anna Luan and Louise Wang from Stanford.

Because a lot of employers and employees are going to realize that employer-provided coverage isn’t worth it – that it makes more economic sense for their employees to get health insurance through the exchanges,” Bhattacharya said.

As of Oct. 1, millions of Americans began receiving federal subsidies to buy health insurance under the Affordable Care Act. People are eligible for a subsidy if they earn between 133 and 400 percent of the poverty level. For individuals, that’s between $14,404 and $43,320. And for a family of four, the range is between $29,326 and $88,200. The subsidies from the government amount to $9,247 for a family of four living on $56,604 a year.

The new health care law assumes that workers who already have affordable insurance through their employers will not use the exchanges, though no mechanism is in place to check that a person using a subsidy isn’t already insured. And while there is a penalty – about $3,000 per employee after the first 50 employees – to  large employers who stop offering health insurance, it is often cheaper for an organization to pay the fine. Providing insurance to cover an employee’s family could cost a business $16,000 or more to cover an employee’s family.

Bhattacharya was interested in understanding the financial implications for the federal government should an employer decide to keep or end its health insurance coverage for employees eligible for subsidies. So he and his colleagues modeled how much the federal government would have to provide in subsidies if an employer stopped providing health insurance to workers, and those employees then used the federal subsidies to buy themselves insurance on the exchanges.  

“These decisions that employers are making about whether or not to provide their employees health insurance has a huge effect on federal government spending,” Bhattacharya said.  

According to the researchers’ calculations, if everyone who would benefit financially from receiving health insurance through the exchanges rather than from their employer chose to buy insurance on the exchanges, the federal government would be on the hook for $132 billion per year to pay for the subsidized insurance.  While not everyone who benefits financially from dropping employer-based coverage will do so, Bhattacharya estimates that federal costs would climb by nearly $7 billion if employers raise health insurance premiums by even just $100 because it would induce millions of employees to switch to exchange-based coverage.

In many instances, Bhattacharya pointed out, companies can still ensure their employees have benefits and make more money by cutting their workers’ health insurance if they’re eligible for subsidies, paying their employees a slightly higher salary and encouraging them to receive the federal subsidies and buy their own policies. But doing so puts a heavier financial burden on the government.

On the flip side, if more employers decide to offer health insurance – perhaps wanting to avoid the small penalty or because of the appearance of not offering a basic benefit – the government could end up spending a lot less on subsidies. But Bhattacharya expects that is unlikely.

The study used data from the Medical Expenditure Panel Survey Household Component – a national survey of household health care use, insurance status, and health expenses, as well as demographic and socioeconomic information – to construct a model.  The model revealed that as employees’ health insurance contributions rise (when their insurance is provided by an employer), employees are increasingly enticed to drop their employer coverage and buy insurance through the exchange. Among workers who qualify for a subsidy and see an increase of $100 in their employer-based premium contribution levels, 2.25 million individuals would choose to instead buy insurance on the exchanges – increasing federal spending for subsidies by $6.7 billion.

“In the model we assume that if there’s a $1 benefit, employees will drop their employer-sponsored coverage. In reality there’s a lot of inertia and you most likely won’t get that $1 increase,” Bhattacharya said. “On the other hand, in the medium run, employers might say ‘employees will benefit if I drop coverage. I can raise their wages, and they’ll get better coverage on the exchanges.’”

Teal Pennebaker is a Washgington, D.C.-based freelance writer and former information editor and external relations coorinator at Stanford Health Policy.

Hero Image
obama signs
President Barack Obama signs the health insurance reform bill on March 23, 2010.
Reuters
All News button
1

Shorenstein APARC
Encina Hall C331
616 Serra Street
Stanford, CA 94305-6055

(650) 724-5656 (650) 723-6530
0
2013-2014 Asia Health Policy Postdoctoral Fellow
triyana_photo.jpg PhD

Margaret (Maggie) Triyana’s main research interests are inequality and human capital investments in developing countries. In particular, she is interested in the effects social policy changes on children’s health outcomes. As a Postdoctoral Fellow, she will analyze the effects of rural-urban migration in Indonesia and China, as well as the impact of health insurance expansion in Indonesia and Vietnam.

Triyana received a PhD in Public Policy from the University of Chicago in 2013.

 

Working Papers

“Do Health Care Providers Respond to Demand-Side Incentives? Evidence from Indonesia“

“The Effects of Community and Household Interventions on Birth Outcomes: Evidence from Indonesia”

“The Longer Term Effects of the ‘Midwife in the Village’ Program in Indonesia”

“The Sources of Wage Growth in a Developing Country” (with Ioana Marinescu)

Encina Hall
616 Serra Street
Stanford, CA 94305-6055

0
CDDRL Pre-doctoral Fellow, 2013-14
West_HS.jpg

Anna West is a 2013-14 pre-doctoral fellow at CDDRL and a PhD candidate in the Department of Anthropology at Stanford. Her dissertation research in Malawi examines how modular global health interventions engage local power structures, patronage systems, and political cultures. Anna combines ethnographic fieldwork and archival research on encounters between government outreach workers, village heads, and rural households to trace the salience of health promotion strategies for the formation and consolidation of ideas, values, and processes of governance and democracy in Malawi. Her work focuses in particular on traditional authorities' involvement in rural health promotion and the significance of chiefly governance for local and national discourse on community participation, human rights, and citizenship. Anna's research has been supported by the National Science Foundation, the Fulbright U.S. Student Program, a U.S. State Department FLAS Fellowship, and Stanford's Center for African Studies.

-

A tremendous amount of radioactive products were discharged as a result of the accident at the Fukushima nuclear power plant in March 2011, which resulted in radioactive contamination of the plant and surrounding areas. While geographical distribution of radioactive iodine, tellurium, and cesium in the surface soils was smoothly (but not always systematically) widespread all over the region, health risk information by the government, media, and other organizations is most likely to be given in terms of administrative boundaries (cf. prefectures, municipalities, etc.) and/or distance from the radiation source.

This paper estimates the effect of such health risk information rather than the actual health risks of radiation on land and other prices in different locations. We find that the prefecture and municipality border effects – but not the distance effect from the nuclear power plant – are significantly related to a reduction in land and other prices after the accident. This shows that people responded to health risk information based on administrative boundaries rather than the actual health risk of radiation after the disaster. Although health risk information based on prefecture and municipality boundaries has an obvious advantage of distilling large and complex risk information into a simple one, the government, media, and other organizations need to recognize and carefully examine the potential of misclassifying non-contaminated areas into contaminated prefectures. Doing so will avoid unintentional consequences to the region’s economy.

Hiroaki Matsuura is currently Departmental Lecturer in the Economy of Japan in the School of Interdisciplinary Area Studies, University of Oxford and a Junior Research Fellow of St. Antony’s College. His main interests are health economics and demography, with a special interest in the relation between laws and population health. Hiroaki received his B.A. in Economics from Keio University, M.A. in Social Science from the University of Chicago, M.S. in Project Management from Northwestern University’s McCormick School of Engineering and Applied Science, and Sc.D. in Global Health and Population (Economics track) from Harvard University’s School of Public Health. In the past, he was affiliated with Institute of Quantitative Social Sciences, Human Rights in Development, and Takemi Program in International Health at Harvard University. He also worked as a research assistant at the National Bureau of Economic Research. His doctoral dissertation research explores a right to health or to health care in national constitutions of 157 countries and state constitutions of the 50 U.S. states and estimates the impact of introducing (or removing) a right to health or to health care into national and state constitutions on health system and population health outcomes. His most recent article, “The Right to Health in Japan: Challenges of a Super Aging Society and Implication from Its 2011 Public Health Emergency” (with Eriko Sase) will be appeared on “Advancing the Human Right to Health”, edited by José M. Zuniga, Stephen P. Marks, and Lawrence O. Gostin, Oxford University Press, 2013. 

Daniel and Nancy Okimoto Conference Room

Hiroaki Matsuura Departmental Lecturer in the Economy of Japan in the School of Interdisciplinary Area Studies Speaker University of Oxford
Seminars
-

More information TBA. 

 

Speaker bio:

David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and chief of infectious diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also co-director of the Center for International Security and Cooperation and senior fellow at the Freeman Spogli Institute for International Studies at Stanford University.

Dr. Relman’s primary research focus is the human indigenous microbiota (microbiome), and in particular, the nature and mechanisms of variation in patterns of microbial diversity and function within the human body, and the basis of microbial community resilience. His work was some of the first to employ modern molecular methods in the study of the microbiome, and provided the first in-depth sequence-based analyses of microbial community structure in humans. During the past few decades, his research has included pathogen discovery and the development of new strategies for identifying previously-unrecognized microbial agents of disease. A resulting publication was cited by the American Society for Microbiology as one of the 50 most important papers in microbiology of the twentieth century. He has also served as an advisor to a number of agencies and departments within the U.S. Government on matters pertaining to host-microbe interactions, emerging infectious diseases, and biosecurity. He co-chaired a widely-cited 2006 study by the National Academies of Sciences (NAS) on “Globalization, Biosecurity, and the Future of the Life Sciences”, and served as vice-chair of a 2011 National Academies study of the science underlying the FBI investigation of the 2001 anthrax mailings. He currently serves as a member of the National Science Advisory Board for Biosecurity (2005-), a member of the Committee on Science, Technology, and Law at the National Academy of Science (2012-15), a member of the Science, Technology & Engineering Advisory Panel for Lawrence Livermore National Laboratory (2012-), as Chair of the Forum on Microbial Threats at the Institute of Medicine (NAS) (2007-), and as President of the Infectious Diseases Society of America (2012-2013).

Dr. Relman received an S.B. (Biology) from MIT (1977), M.D. (magna cum laude) from Harvard Medical School (1982), completed his clinical training in internal medicine and infectious diseases at Massachusetts General Hospital, served as a postdoctoral fellow in microbiology at Stanford University, and joined the faculty at Stanford in 1994. He received an NIH Director’s Pioneer Award in 2006, was elected a Fellow of the American Academy of Microbiology in 2003 and the American Association for Advancement of Science in 2010, and was elected a Member of the Institute of Medicine in 2011.

 

 

Reuben W. Hills Conference Room

CISAC
Stanford University
Encina Hall, E209
Stanford, CA 94305-6165

0
Senior Fellow at the Freeman Spogli Institute for International Studies
Thomas C. and Joan M. Merigan Professor
Professor of Medicine
Professor of Microbiology and Immunology
1-RSD13_085_0052a-001.jpg MD

David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford, and served as science co-director at the Center for International Security and Cooperation at Stanford from 2013-2017. He is currently director of a new Biosecurity Initiative at FSI.

Relman was an early pioneer in the modern study of the human indigenous microbiota. Most recently, his work has focused on human microbial community assembly, and community stability and resilience in the face of disturbance. Ecological theory and predictions are tested in clinical studies with multiple approaches for characterizing the human microbiome. Previous work included the development of molecular methods for identifying novel microbial pathogens, and the subsequent identification of several historically important microbial disease agents. One of his papers was selected as “one of the 50 most important publications of the past century” by the American Society for Microbiology.

Dr. Relman received an S.B. (Biology) from MIT, M.D. from Harvard Medical School, and joined the faculty at Stanford in 1994. He served as vice-chair of the NAS Committee that reviewed the science performed as part of the FBI investigation of the 2001 Anthrax Letters, as a member of the National Science Advisory Board on Biosecurity, and as President of the Infectious Diseases Society of America. He is currently a member of the Intelligence Community Studies Board and the Committee on Science, Technology and the Law, both at the National Academies of Science. He has received an NIH Pioneer Award, an NIH Transformative Research Award, and was elected a member of the National Academy of Medicine in 2011.

Stanford Health Policy Affiliate
CV
David Relman Thomas C. and Joan M. Merigan Professor, Departments of Medicine and of Microbiology and Immunology, Stanford School of Medicine; CISAC Co-Director; FSI Senior Fellow; Stanford Health Policy Affiliate Speaker
Seminars
-

Co-sponsored by the Center of East Asian Studies, Stanford University

Prominent health policy expert—Rachel Lu from Taiwan—will share her view on recent health policy developments in the region, drawing on her extensive research and policy background.

Jui-fen Rachel Lu, Sc.D., is a Professor in the Department of Health Care Management, at Chang Gung University (CGU) in Taiwan, where she teaches comparative health systems, health economics, and health care financing and has served as department chair (2000-2004), Associate Dean (2009-2010) and Dean of College of Management (2010-2013).  She earned her B.S. from National Taiwan University, and her M.S. and Sc.D. from Harvard University, and she was also a Takemi Fellow at Harvard (2004-2005) and is an Honorary Professor at Hong Kong University (2007-2014), a guest professor at Huazhong University of Science and Technology (2010-2013), and an adjunct professor at Xi’an Jiaotong University (2011-2014) in China.  Her devotion to teaching driven by her firm belief in the value of education and investment in human minds was recognized by the Award of Excellence in Teaching conferred by CGU in both 2002 and 2013.

Her research focuses on 1) the equity issues of the health care system; 2) impact of the NHI program on health care market and household consumption patterns; 3) comparative health systems in Asia-Pacific region.  She is a long-time and active member of Equitap (Equity in Asia-Pacific Health Systems) research network and is currently the coordinator for the catastrophic payment component of Equitap II research project which involves 21 country teams and is jointly funded by IDRC, AusAID, and ADB.  Professor Lu has also been appointed to serve as a member on various government committees dealing with health care issues in Taiwan, such as National Health Insurance Supervisory Committee (DOH), Hospital Management Committee(DOH), and Hospital Global Budget Payment Committee (BNHI), etc.  Dr. Lu received the Minister Wang Jin Naw Memorial Award for Best Paper in Health Care Management presented by Kimma Chang Foundation in 2002 and was the recipient of IBM Faculty Award in 2009.  She has published papers in Health Affairs, Medical Care, Journal of Health Economics, Health Economics, Social Science and Medicine, Health Economics, Policy and Law, Osteoporosis International, Health and Quality of Life Outcomes, and Taiwan Economic Review etc, and is the author of “Health Economics”(a textbook in Chinese) and various book chapters.  

Philippines Conference Room
Encina Hall 3rd Floor Central
616 Serra Street, CA 94305

Jui-fen Rachel Lu Professor in the Department of Health Care Management Speaker Chang Gung University in Taiwan
Seminars

Beckman Center, B271
Stanford University
Stanford, California 94305

(650) 725-6991 (650) 725-1534
0
Associate Professor of Genetics
gitler.jpg
Faculty Fellow at the Stanford Center at Peking University, June to August of 2014
Paragraphs

Distributed irrigation systems are those in which the water access (via pump or human power), distribution (via furrow, watering can, sprinkler, drip lines, etc.), and use all occur at or near the same location. Distributed systems are typically privately owned and managed by individuals or groups, in contrast to centralized irrigation systems, which tend to be publicly operated and involve large water extractions and distribution over significant distances for use by scores of farmers. Here we draw on a growing body of evidence on smallholder farmers, distributed irrigation systems, and land and water resource availability across sub-Saharan Africa (SSA) to show how investments in distributed smallholder irrigation technologies might be used to (i) use the water sources of SSA more productively, (ii) improve nutritional outcomes and rural development throughout SSA, and (iii) narrow the income disparities that permit widespread hunger to persist despite aggregate economic advancement.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Proceedings of the National Academy of Sciences
Authors
Rosamond L. Naylor
Subscribe to Health and Medicine